Monitor for any filings of a prospectus supplement, which would signal the start of actual sales. The stock is likely to face significant downward pressure if the selling stockholders begin selling, especially given the small market cap and high percentage of shares being offered. This is a material negative event for existing shareholders.
Price Chart
Executive Summary
Neuronetics (STIM) has filed an S-3 shelf registration to allow selling stockholders (Madryn affiliates) to resell up to 20,737,061 shares. This is a secondary offering where the company receives no proceeds. The potential sale of 30.3% of outstanding shares could significantly dilute existing shareholders and pressure the stock price, especially given the company's small market cap of $93M.
Key Financial Metrics
Key Facts
- S-3 shelf registration filed for Madryn-affiliated selling stockholders to resell up to 20,737,061 shares.
- Selling stockholders (Madryn Select Opportunities, Madryn Health Partners II, and Madryn Health Partners II Cayman) currently own 20,737,061 shares, representing 30.3% of outstanding shares.
- The company will receive no proceeds from the sale; all proceeds go to the selling stockholders.
- The offering represents a significant potential dilution, as it could place 30.3% of the company's shares on the market.
- The company's market cap is $93M, and the maximum aggregate offering price is $26.1M, meaning the sale could represent over 28% of the company's total value.
Financial Impact
The potential sale of 20.7 million shares, representing 30.3% of the float, could result in a significant market overhang and downward price pressure. The maximum offering value of $26.1M is 28% of the company's $93M market cap.
Risk Factors
- Significant share dilution and downward pressure on the stock price if the selling stockholders sell all or a large portion of their shares.
- The company's small market cap makes it vulnerable to a large block sale.
- The company has a history of losses and negative cash flow, which increases the risk associated with this dilutive offering.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-111081 |
| Document: d118087dexfilingfees.htm | 0001193125-26-111081 |
| Document: d118087dex51.htm | 0001193125-26-111081 |
| Document: d118087dex231.htm | 0001193125-26-111081 |
| Document: 0001193125-26-111081-index-headers.html | 0001193125-26-111081 |
| Document: 0001193125-26-111081-index.html | 0001193125-26-111081 |
| Document: 0001193125-26-111081.txt | 0001193125-26-111081 |
| CONTEXT: 10-Q (2025-11-04) | 0001104659-25-105924 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 11w ago | 8-K | $3.19 $3.21 | ▲ +0.63% | ▲ +0.38% | $2.24 (−29.78%) |
Aug 11, 2026 11w ago | Press Release | $3.19 $3.21 | ▲ +0.63% | ▲ +0.38% | $2.24 (−29.78%) |
Jun 23, 2026 17w ago | 8-K | $1.26 $1.27 | ▲ +0.79% | ▲ +0.65% | $2.24 (+77.78%) |
May 22, 2026 22w ago | 8-K | $1.20 $1.22 | ▲ +1.67% | ▲ +1.08% | $2.24 (+86.67%) |
May 5, 2026 25w ago | 8-K | $2.17 $1.91 | ▼ −11.98% | ▼ −13.37% | $2.24 (+3.23%) |
May 5, 2026 25w ago | Press Release | $2.17 $1.91 | ▼ −11.98% | ▼ −13.37% | $2.24 (+3.23%) |
Apr 21, 2026 26w ago | Press Release | $1.50 $1.59 | ▲ +6.00% | ▲ +4.98% | $2.24 (+49.33%) |
Apr 13, 2026 28w ago | EFFECT | $1.39 $1.43 | ▼ −2.88% | ▼ −1.67% | $2.24 (−61.15%) |
Mar 19, 2026 31w ago | Insider Cluster | $1.52 $1.45 | ▼ −4.29% | ▼ −2.55% | $2.24 (+47.85%) |
Mar 19, 2026 31w ago | Insider Cluster | $1.52 $1.45 | ▼ −4.29% | ▼ −2.55% | $2.24 (+47.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers